Also, dot plots show the expression of NR2F1, TGFB1, SOX9, and RARB by cell type in each immunohistological subtype in single-cell Cohort 2.
To this end, we believe that NR2F1 expression in the bulk tumor does not reflect the expression in the cancer cells, thus its value as a biomarker is in doubt.